Dr. Ellen Chieko Deconinck, MD

Dr. Deconinck practices at Sunnyvale Center in Sunnyvale, California.

Dr. Deconinck's NPI, 1114977865, was assigned on May 12, 2006. Dr. Deconinck graduated from Stanford University School Of Medicine in 2005. Dr. Deconinck holds California license A79762.

Dr. Deconinck's primary practice is Sunnyvale Center, at 401 Old San Francisco Rd, 2nd Fl, Sunnyvale, CA 94086. The practice phone is (408) 730-6227.

Dr. Deconinck's primary practice is Sunnyvale Center in Sunnyvale, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Deconinck to 1 more group practice or clinic, named with a free account. Dr. Deconinck's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deconinck practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Deconinck's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Deconinck is board certified in dermatology by the American Board of Dermatology. Dr. Deconinck is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Deconinck treats.

CMS data shows 3,426 Medicare services from Dr. Deconinck across 13 procedure codes in 2024, for 604 Medicare patients. Medicare paid $165,554 for them. Every service was in an office.

CMS counts 604 Medicare patients who saw Dr. Deconinck in 2024. The largest group is 65 to 74, with 268 patients. 71% of them have high cholesterol, and 57% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Deconinck's median patient age at 63, with 65% women.

In 2024, Dr. Deconinck wrote 641 Medicare Part D claims for 238 patients. 98% of them were for generic drugs. CMS names the drug for 519 of them, across 16 drugs with 11 or more claims each, at $12,736 in total drug cost. In 2023, CMS named 489 claims across 16 drugs.

Dr. Deconinck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deconinck as offering telehealth. CMS counts 969 procedures of removal of skin lesions by Dr. Deconinck, more than 93% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 17 general payments to Dr. Deconinck from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $196.

Dr. Deconinck graduated from Stanford University School Of Medicine in 2005.

Dr. Deconinck is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.